应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VIVS VivoSim Lab, Inc.
盘后交易 09-09 16:43:13 EDT
0.2750
-0.0067
-2.38%
盘后
0.2800
+0.0050
+1.82%
16:31 EDT
最高
0.2893
最低
0.2723
成交量
37.68万
今开
0.2820
昨收
0.2817
日振幅
6.03%
总市值
456.13万
流通市值
446.61万
总股本
1,659万
成交额
10.45万
换手率
2.32%
流通股本
1,624万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
VivoSim Lab, Inc. 宣布完成400万美元定向增发 依据纳斯达克规则以市价定价 获单一医疗健康领域机构投资者认购
美股速递 · 07-16
VivoSim Lab, Inc. 宣布完成400万美元定向增发 依据纳斯达克规则以市价定价 获单一医疗健康领域机构投资者认购
VivoSim Lab获礼来500万美元里程碑付款 并预期2027财年营收增长超500%
美股速递 · 07-15
VivoSim Lab获礼来500万美元里程碑付款 并预期2027财年营收增长超500%
公司概况
公司名称:
VivoSim Lab, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
VivoSim Labs, Inc.成立于2012年1月,从事开发和商业化可以应用在药物发现和开发,进行生物学研究,作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织,通过构建三维创作,复制天然人类生物学的潜力。
发行价格:
--
{"stockData":{"symbol":"VIVS","market":"US","secType":"STK","nameCN":"VivoSim Lab, Inc.","latestPrice":0.275,"timestamp":1788984000000,"preClose":0.2817,"halted":0,"volume":376838,"hourTrading":{"tag":"盘后","latestPrice":0.28,"preClose":0.275,"latestTime":"16:31 EDT","volume":1044,"amount":292.26057552000003,"timestamp":1788985911257,"change":0.005,"changeRate":0.018182,"amplitude":0.024364},"delay":0,"changeRate":-0.02378416755413555,"floatShares":16240300,"shares":16586500,"eps":-4.46,"marketStatus":"盘后交易","change":-0.0067,"latestTime":"09-09 16:43:13 EDT","open":0.282,"high":0.2893,"low":0.2723,"amount":104514.11249972,"amplitude":0.060348,"askPrice":0.2849,"askSize":5,"bidPrice":0.273,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-4.46,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788998400000},"marketStatusCode":4,"adr":0,"listingDate":1373515200000,"exchange":"NASDAQ","adjPreClose":0.2817,"preHourTrading":{"tag":"盘前","latestPrice":0.2821,"preClose":0.2817,"latestTime":"09:27 EDT","volume":13292,"amount":3690.4195907200005,"timestamp":1788960470438,"change":0.0004,"changeRate":0.00142,"amplitude":0.076677},"postHourTrading":{"tag":"盘后","latestPrice":0.28,"preClose":0.275,"latestTime":"16:31 EDT","volume":1044,"amount":292.26057552000003,"timestamp":1788985911257,"change":0.005,"changeRate":0.018182,"amplitude":0.024364},"volumeRatio":0.806243},"requestUrl":"/m/hq/s/VIVS/wiki","defaultTab":"wiki","newsList":[{"id":"1193635789","title":"VivoSim Lab, Inc. 宣布完成400万美元定向增发 依据纳斯达克规则以市价定价 获单一医疗健康领域机构投资者认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1193635789","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193635789?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:31","pubTimestamp":1784205078,"startTime":"0","endTime":"0","summary":"VivoSim Lab, Inc. 已宣布其定向增发定价,成功募集400万美元资金。此次发行严格依据纳斯达克规则,以市价定价,并成功获得一家专注于医疗健康领域的单一机构投资者全额认购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122047503","title":"VivoSim Lab获礼来500万美元里程碑付款 并预期2027财年营收增长超500%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122047503","media":"美股速递","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122047503?lang=zh_cn&edition=full","pubTime":"2026-07-15 20:06","pubTimestamp":1784117197,"startTime":"0","endTime":"0","summary":"VivoSim Lab, Inc.宣布,已收到来自全球制药巨头礼来公司的一笔500万美元里程碑付款。与此同时,公司发布了业绩指引,预计在2027财年将实现超过500%的营收增长。这一里程碑付款的达成,标志着双方在特定合作项目上取得了关键进展。VivoSim并未披露具体的合作细节,但此类付款通常与药物研发过程中达到预设的临床或监管目标相关联。投资者将密切关注VivoSim后续的财务报告和业务进展,以验证这一雄心勃勃的增长目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivosim.ai","stockEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":-0.3981},{"period":"3month","weight":-0.7613},{"period":"6month","weight":-0.8485},{"period":"1year","weight":-0.8869},{"period":"ytd","weight":-0.8444}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VivoSim Labs, Inc.成立于2012年1月,从事开发和商业化可以应用在药物发现和开发,进行生物学研究,作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织,通过构建三维创作,复制天然人类生物学的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.001588},{"month":2,"riseRate":0.538462,"avgChangeRate":0.0713},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.135222},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.007295},{"month":5,"riseRate":0.461538,"avgChangeRate":0.044355},{"month":6,"riseRate":0.153846,"avgChangeRate":-0.092831},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.040342},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.082026},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.037174},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.055078},{"month":11,"riseRate":0.461538,"avgChangeRate":0.059307},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.024045}],"exchange":"NASDAQ","name":"VivoSim Lab, Inc.","nameEN":"VivoSim Lab, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VivoSim Lab, Inc.,VIVS,VivoSim Lab, Inc.股票,VivoSim Lab, Inc.股票老虎,VivoSim Lab, Inc.股票老虎国际,VivoSim Lab, Inc.行情,VivoSim Lab, Inc.股票行情,VivoSim Lab, Inc.股价,VivoSim Lab, Inc.股市,VivoSim Lab, Inc.股票价格,VivoSim Lab, Inc.股票交易,VivoSim Lab, Inc.股票购买,VivoSim Lab, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}